World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 27 February 2024
Main ID:  NCT04005638
Date of registration: 17/06/2019
Prospective Registration: No
Primary sponsor: University Hospital, Bordeaux
Public title: Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia BIOCAI
Scientific title: Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
Date of first enrolment: February 2, 2019
Target sample size: 200
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/ct2/show/NCT04005638
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
France
Contacts
Name:     Jean-François VIALLARD, Prof
Address: 
Telephone: 05.57.65.64.83
Email: jean-françois.viallard@chu-bordeaux.fr
Affiliation: 
Name:     Jean-François VIALLARD, Prof
Address: 
Telephone:
Email:
Affiliation:  CHU Bordeaux
Name:     Jean-François VIALLARD, Prof
Address: 
Telephone: 05.57.65.64.83
Email: jean-françois.viallard@chu-bordeaux.fr
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients over 16 years old.

- Patients with autoimmune cytopenia according to the definitions reported in the latest
update of the French National Care Protocol (PNDS 2017).

- Affiliated person or beneficiary of a social security scheme.

- Free, informed and written consent signed by the participant and the investigator (at
the latest on the day of inclusion and before any examination required by the
research).

Exclusion Criteria:

- Positivity for HIV, Hepatitis C or B virus.

- Pregnant or lactating woman.

- Patient undergoing treatment for autoimmune cytopenia



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Immune Thrombocytopenia
Autoimmune Neutropenia
Autoimmune Hemolytic Anemia
Intervention(s)
Biological: urine sample
Biological: blood sample
Primary Outcome(s)
Number of patients with autoimmune cytopenia at diagnosis, or followed but not treated with a biological library (serum, plasma, DNA) [Time Frame: At baseline (Day 0)]
Secondary Outcome(s)
Secondary ID(s)
CHUBX 2018/13
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ministry for Health and Solidarity, France
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history